Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASTRAL-4: Epclusa in HCV with Decompensated Cirrhosis
NCT02201901Phase 3Completed
- Sponsor
- Gilead Sciences
- Start
- Jul 2014
- Primary completion
- Aug 2015
- Modality
- Reversible Covalent Inhibitors, Allosteric Modulators, Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 3 trial of velpatasvir in hepatitis C (HCV), sponsored by Gilead Sciences. Started Jul 2014; status: completed.
02
Drugs
velpatasvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT02201901.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02201901.